Provides that for a substance use disorder outpatient treatment episode of care by a provider licensed, certified or otherwise authorized by the office of addiction services and supports, an insured shall only be responsible for a cost sharing fee not to exceed two hundred fifty dollars.
Summary
Bill S01763 amends the New York insurance law to regulate cost-sharing fees for outpatient treatment at substance use treatment programs. Specifically, it establishes that individuals seeking outpatient treatment for substance use disorders will only be responsible for a maximum cost-sharing fee of $250 per episode of care, which can include up to 60 visits with the same provider. The bill also stipulates that insurers cannot impose preauthorization or concurrent review for the first four weeks of treatment, ensuring that care is more accessible during this critical period.
The legislation aims to enhance access to necessary treatment for individuals facing substance use disorders by reducing financial barriers. Insurers are required to cover all other financial obligations to the treatment facilities, thereby ensuring that patients are not burdened with excessive out-of-pocket costs. The bill also emphasizes the importance of evidence-based treatment, mandating that facilities utilize clinically approved assessment tools to confirm the medical necessity of the treatment provided.
The bill is expected to have a significant impact on state laws governing insurance coverage for substance use disorder treatments. It aligns with ongoing efforts to address the opioid crisis and improve mental health services by making outpatient treatment more affordable and accessible. By limiting the financial responsibilities of patients, the bill aims to encourage more individuals to seek help without the fear of overwhelming costs.
General sentiment surrounding the bill has been positive, as evidenced by the unanimous support in committee votes and a strong majority during the final Senate floor vote. This reflects a bipartisan recognition of the need for improved access to substance use disorder treatment in New York. The bill has garnered support from various stakeholders, including healthcare providers and advocacy groups focused on addiction recovery.
Impact
The passage of Bill S01763 will modify existing insurance laws in New York to ensure that individuals seeking outpatient treatment for substance use disorders face lower financial barriers. By capping cost-sharing fees and eliminating preauthorization requirements for initial treatment, the bill aims to facilitate timely access to care. This legislative change is expected to influence how insurers structure their coverage for substance use treatment, potentially leading to broader reforms in mental health and addiction services across the state.
Sentiment
The sentiment around Bill S01763 is largely supportive, with unanimous votes in committee and a strong majority in the final Senate vote indicating bipartisan agreement on the importance of improving access to substance use disorder treatment. Stakeholders, including healthcare providers and advocacy groups, have expressed approval for the bill, recognizing its potential to alleviate financial burdens on patients seeking necessary care.
Contention
While the overall sentiment is positive, some contention may arise regarding the implications for insurers and the financial impact on their operations. Concerns may be raised about how the bill's requirements could affect the cost structures of insurance policies and the sustainability of coverage for substance use treatment. However, specific points of contention have not been prominently highlighted in discussions or voting records.
Same As
Provides that for a substance use disorder outpatient treatment episode of care by a provider licensed, certified or otherwise authorized by the office of addiction services and supports, an insured shall only be responsible for a cost sharing fee not to exceed two hundred fifty dollars.
A bill for an act establishing a veterans recovery pilot program and fund for the reimbursement of expenses related to providing hyperbaric oxygen treatment to eligible veterans and making appropriations.(Formerly HF 326.)
A bill for an act establishing a veterans recovery pilot program and fund for the reimbursement of expenses related to providing hyperbaric oxygen treatment to eligible veterans and making appropriations.(See HF 518.)